NCT00001680已完成2 期
A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 17
- 试验地点
- 2
研究概览
简要总结
The purpose of this double-masked, pilot trial is to determine whether 20 percent thalidomide ointment is safe and effective for the treatment of chronic discoid lupus erythematosus (CDLE) when used under an occlusive dressing. Seventeen patients with two similar lesions will have lesions randomized to receive either intervention or placebo therapy.
详细描述
The purpose of this double-masked, pilot trial is to determine whether 20 % thalidomide ointment is safe and effective for the treatment of chronic discoid lupus erythematosus (CDLE) when used under an occlusive dressing. Seventeen patients with two similar lesions will have lesions randomized to receive either intervention or placebo therapy.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
终止
2 期
Safety and Efficacy Study of Thalomid in Patients With Chronic PancreatitisChronic PancreatitisNCT00469703Winthrop University Hospital10
已完成
2 期
Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma PatientsMALT LymphomaNCT00373646Medical University of Vienna8
已完成
2 期
A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerProstatic NeoplasmNCT00001446National Cancer Institute (NCI)64
尚未招募
2 期
Nu-3 Gel for Infected Diabetic Foot UlcersDiabetic Foot InfectionNCT06020235Lakewood-Amedex Inc60
已完成
1 期
Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic DermatitisAtopic DermatitisNCT00833079Taro Pharmaceuticals USA500